Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
17,755,754
-
Share change
-
-170,705
-
Total reported value
-
$243,788,540
-
Put/Call ratio
-
9.2%
-
Price per share
-
$13.74
-
Number of holders
-
72
-
Value change
-
-$3,024,155
-
Number of buys
-
34
-
Number of sells
-
39
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q1 2023
As of 31 Mar 2023 IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,755,754 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, BAKER BROS. ADVISORS LP, Artal Group S.A., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, UBS ASSET MANAGEMENT AMERICAS INC, and GOLDMAN SACHS GROUP INC.
This table shows 72 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.